AKT1 and breast cancer: Consistent with previous preclinical observations in BC cell lines, and reflecting known direct anti-neoplastic activity of AKT inhibition, we observed greater expression of pro-apoptotic genes and upstream receptor tyrosine kinases including IGF-1R and HER3 following treatment with MK-2206 (19).